Detalles de la búsqueda
1.
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.
Oncotarget
; 14: 622-636, 2023 06 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335291
2.
Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer.
Oncotarget
; 14: 890-892, 2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861386
Resultados
1 -
2
de 2
1
Próxima >
>>